Publicaciones en colaboración con investigadores/as de University of Washington (5)

2024

  1. The evolving value assessment of cancer therapies: Results from a modified Delphi study

    Health Policy OPEN, Vol. 6

2023

  1. Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 2, pp. 198-205

2020

  1. Association of pathologic complete response with long-term survival outcomes in triple-negative breast cancer: A meta-analysis

    Cancer Research, Vol. 80, Núm. 24, pp. 5427-5434

  2. Evaluation of pathologic complete response as a surrogate for long-term survival outcomes in triple-negative breast cancer

    JNCCN Journal of the National Comprehensive Cancer Network, Vol. 18, Núm. 8, pp. 1096-1104

2013

  1. Dasatinib plus capecitabine for advanced breast cancer: Safety and efficacy in phase I study CA180004

    Clinical Cancer Research, Vol. 19, Núm. 7, pp. 1884-1893